
ProtoKinetix, Incorporated – OTC:PKTX
ProtoKinetix, Incorporated stock price today
ProtoKinetix, Incorporated stock price monthly change
ProtoKinetix, Incorporated stock price quarterly change
ProtoKinetix, Incorporated stock price yearly change
ProtoKinetix, Incorporated key metrics
Market Cap | 9.50M |
Enterprise value | N/A |
P/E | -2.8 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 21.74 |
PEG ratio | -0.03 |
EPS | N/A |
Revenue | N/A |
EBITDA | -351.58K |
Income | -400.46K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProtoKinetix, Incorporated stock price history
ProtoKinetix, Incorporated stock forecast
ProtoKinetix, Incorporated financial statements
Jun 2023 | 0 | -115.57K | |
---|---|---|---|
Sep 2023 | 0 | -80.39K | |
Dec 2023 | 66.90K | -112.47K | -168.1% |
Mar 2024 | 0 | -92.02K |
Jun 2023 | 466980 | 13.25K | 2.84% |
---|---|---|---|
Sep 2023 | 450895 | 12.56K | 2.79% |
Dec 2023 | 480557 | 44.69K | 9.3% |
Mar 2024 | 461404 | 67.56K | 14.64% |
Jun 2023 | -143.75K | -19.52K | 175K |
---|---|---|---|
Sep 2023 | -69.89K | -1.36K | 65K |
Dec 2023 | -77.46K | -24.52K | 110K |
Mar 2024 | -57.83K | -9.73K | 50K |
ProtoKinetix, Incorporated other data
Period | Buy | Sel |
---|---|---|
May 2023 | 3750000 | 0 |
Jun 2023 | 2000000 | 0 |
Aug 2023 | 1500000 | 0 |
Oct 2023 | 20000 | 0 |
Dec 2023 | 7333334 | 0 |
Mar 2024 | 3166667 | 0 |
Insider | Compensation |
---|---|
Mr. Michael Richard Guzzetta CPA (1958) Chief Financial Officer | $60,000 |
-
What's the price of ProtoKinetix, Incorporated stock today?
One share of ProtoKinetix, Incorporated stock can currently be purchased for approximately $0.01.
-
When is ProtoKinetix, Incorporated's next earnings date?
Unfortunately, ProtoKinetix, Incorporated's (PKTX) next earnings date is currently unknown.
-
Does ProtoKinetix, Incorporated pay dividends?
No, ProtoKinetix, Incorporated does not pay dividends.
-
How much money does ProtoKinetix, Incorporated make?
ProtoKinetix, Incorporated has a market capitalization of 9.50M.
-
What is ProtoKinetix, Incorporated's stock symbol?
ProtoKinetix, Incorporated is traded on the OTC under the ticker symbol "PKTX".
-
What is ProtoKinetix, Incorporated's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ProtoKinetix, Incorporated?
Shares of ProtoKinetix, Incorporated can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ProtoKinetix, Incorporated's key executives?
ProtoKinetix, Incorporated's management team includes the following people:
- Mr. Michael Richard Guzzetta CPA Chief Financial Officer(age: 67, pay: $60,000)
-
When ProtoKinetix, Incorporated went public?
ProtoKinetix, Incorporated is publicly traded company for more then 23 years since IPO on 22 Apr 2002.
-
What is ProtoKinetix, Incorporated's official website?
The official website for ProtoKinetix, Incorporated is protokinetix.com.
-
Where are ProtoKinetix, Incorporated's headquarters?
ProtoKinetix, Incorporated is headquartered at 412 Mulberry Street, Marietta, OH.
-
How can i contact ProtoKinetix, Incorporated?
ProtoKinetix, Incorporated's mailing address is 412 Mulberry Street, Marietta, OH and company can be reached via phone at +7 404345041.
ProtoKinetix, Incorporated company profile:

ProtoKinetix, Incorporated
protokinetix.comOTC
0
Biotechnology
Healthcare
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
Marietta, OH 45750
CIK: 0001128189
ISIN: US7437221002
CUSIP: 743722100